Additional file 1: Supplemental Table 1. Multi-Variable Incidence Relative Ratio (IRR) for Length of Stay. Adjusted for Multiple Comparison (n=141). *p<0.05. †p<.00625 per Bonferroni correction

DataCite Commons2024-08-13 更新80

Supplementary Material for: Rest or 30-Min Walk as Exercise Intervention (RESTOREX) in Myasthenia Gravis: A Randomized Controlled Trial

重症肌无力

干预效果评估

Introduction: There is a lack of evidence about the usefulness of exercise or rest in myasthenia gravis (MG). This study is aimed to evaluate the efficacy and safety of exercise or rest in MG. Methods

NIAID Data Ecosystem50

Myasthenia gravis in clinical practice

重症肌无力

临床管理

ABSTRACT Background: Myasthenia gravis is largely a treatable disease, but it can result in significant morbidity and even mortality, which can usually be avoided, or at least mitigated, with timely d

DataCite Commons2022-08-21 更新100

Table_2_Iron metabolism patterns in non-anemic patients with myasthenia gravis: A cross-sectional and follow-up study.docx

重症肌无力

铁代谢

Background and purposeIron metabolism in myasthenia gravis (MG) and factors associated with it are explored by few published studies. Therefore, this study aimed to compare iron metabolism patterns be

NIAID Data Ecosystem60

Data for: Stopping Oral Steroid Sparing Agents at Initiation of Rituximab in Myasthenia Gravis

资源简介：

相关数据集